Klaus W. Wagner
Net Worth
Last updated:
What is Klaus W. Wagner net worth?
The estimated net worth of Dr. Klaus W. Wagner is at least $11,648,825 as of 17 Feb 2021. He owns shares worth $4,948,450 as insider, has earned $4,300,095 from insider trading and has received compensation worth at least $2,400,280 in Inhibrx Biosciences, Inc..
What is the salary of Klaus W. Wagner?
Dr. Klaus W. Wagner salary is $600,070 per year as Chief Medical Officer & Executive Vice President in Inhibrx Biosciences, Inc..
How old is Klaus W. Wagner?
Dr. Klaus W. Wagner is 52 years old, born in 1973.
What stocks does Klaus W. Wagner currently own?
As insider, Dr. Klaus W. Wagner owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | Chief Medical Officer & Executive Vice President | 215,150 | $23 | $4,948,450 |
What does Inhibrx Biosciences, Inc. do?
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California.
Klaus W. Wagner insider trading
Inhibrx Biosciences, Inc.
Dr. Klaus W. Wagner has made 2 insider trades in 2021, according to the Form 4 filled with the SEC. Most recently he sold 19,559 units of INBX stock worth $494,647 on 17 Feb 2021.
The largest trade he's ever made was exercising 156,474 units of INBX stock on 16 Feb 2021. As of 17 Feb 2021 he still owns at least 215,150 units of INBX stock.
Inhibrx Biosciences key executives
Inhibrx Biosciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Brendan P. Eckelman Ph.D. (46) Founder, Chief Scientific Officer & Executive Vice President of Corporation Strategy
- Dr. Klaus W. Wagner (52) Chief Medical Officer & Executive Vice President
- Mr. Mark Paul Lappe (57) Founder, Chairman, Pres & Chief Executive Officer